Marshall Urist - EVP, Research & Investments at Royalty Pharma plc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Research & Investments
Issuer Symbol
RPRX on Nasdaq
All Insider Reports
All Insider Reports

Marshall Urist - trading volume in the past year for Royalty Pharma plc

Holdings reported by Marshall Urist for Royalty Pharma plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Shares 80,000 $3,078,600 $38.48 02 Jan 2026 By Sandy Lamm LLC
Class A Ordinary Shares 19,020 $734,932 $38.64 02 Jan 2026 By IRA
Class A Ordinary Shares 7,398 $285,858 $38.64 02 Jan 2026 Direct
Class E Ordinary Shares 1,356,528 16 May 2025 Indirect Class A Ordinary Shares
LP interests in RPI US Partners 2019, LP 247,412 07 Nov 2025 By Sandy Lamm LLC Class A Ordinary Shares

Transactions reported by Marshall Urist for Royalty Pharma plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.